Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: renovanz m. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
Proposed definition of competencies for surgical neuro-oncology training.
Kamp MA, Malzkorn B, von Sass C, DiMeco F, Hadjipanayis CG, Senft C, Rapp M, Gepfner-Tuma I, Fountas K, Krieg SM, Neukirchen M, Florian IȘ, Schnell O, Mijderwijk HJ, Perin A, Baumgarten P, van Lieshout JH, Thon N, Renovanz M, Kahlert U, Spoor JKH, Hänggi D, McLean AL, Mäurer M, Sarrubbo S, Freyschlag CF, Schmidt NO, Vergani F, Jungk C, Stein M, Forster MT, Weinberg JS, Sinclair J, Belykh E, Bello L, Mandonnet E, Moiyadi A, Sabel M. Kamp MA, et al. Among authors: renovanz m. J Neurooncol. 2021 May;153(1):121-131. doi: 10.1007/s11060-021-03750-6. Epub 2021 Apr 21. J Neurooncol. 2021. PMID: 33881726 Free PMC article.
Benchmarking palliative care practices in neurooncology: a german perspective.
Lawson McLean AC, Lawson McLean A, Ernst T, Forster MT, Freyschlag C, Gempt J, Goldbrunner R, Grau S, Jungk C, van Oorschot B, Rosahl SK, Wedding U, Senft C, Kamp MA; German Consortium for Excellence in Neurooncology, Palliative Care (GCE-NPC). Lawson McLean AC, et al. J Neurooncol. 2024 May 2. doi: 10.1007/s11060-024-04674-7. Online ahead of print. J Neurooncol. 2024. PMID: 38696050
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival.
Feucht D, Haas P, Skardelly M, Behling F, Rieger D, Bombach P, Paulsen F, Hoffmann E, Hauser TK, Bender B, Renovanz M, Niyazi M, Tabatabai G, Tatagiba M, Roder C. Feucht D, et al. Among authors: renovanz m. Neurooncol Adv. 2024 Apr 3;6(1):vdae053. doi: 10.1093/noajnl/vdae053. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38680987 Free PMC article.
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review.
Millward CP, Keshwara SM, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Dirven L, Grundy PL, Islim AI, Javadpour M, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD; EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Millward CP, et al. Neurooncol Adv. 2024 Mar 2;6(1):vdae030. doi: 10.1093/noajnl/vdae030. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38596717 Free PMC article.
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review.
Millward CP, Islim AI, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Dirven L, Grundy PL, Javadpour M, Keshwara SM, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD; EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Millward CP, et al. Neurooncol Adv. 2024 Mar 19;6(1):vdae042. doi: 10.1093/noajnl/vdae042. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38596715 Free PMC article.
Editorial: Autoimmune complications of modern cancer therapies.
Möhn N, Renovanz M, Hagin D, Skripuletz T. Möhn N, et al. Among authors: renovanz m. Front Immunol. 2024 Jan 5;14:1357825. doi: 10.3389/fimmu.2023.1357825. eCollection 2023. Front Immunol. 2024. PMID: 38250085 Free PMC article. No abstract available.
Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative.
Kurz SC, Stammberger A, Rosahl SK, Abrey LE, Albert NL, von Baumgarten L, Gempt J, Grosu AL, Leidgens V, McLean A, Renovanz M, Schwarzenberger J, Sevenich L, Urbanic Purkart T, Combs SE, Tabatabai G, Hegi M, Nowosielski M. Kurz SC, et al. Among authors: renovanz m. Neuro Oncol. 2023 Dec 8;25(12):2302-2304. doi: 10.1093/neuonc/noad157. Neuro Oncol. 2023. PMID: 37738478 No abstract available.
80 results